Table 2. The correlation of LATS1 protein expression with clinicopathologic features in GC patients.

Clinicopathologic features	Cases (n)	LATS1 Expression		P
		Low	High
Age
≥ 60	29	18	11
< 60	60	40	20	0.871
Gender
Female	20	15	5
Male	69	43	26	0.297
Tumor size (cm)
< 3.5	17	9	8
≥ 3.5	72	49	23	0.242
Pathological stage
I/II	32	21	11
III/IV	57	37	20	0.946
T classification
T1/T2	11	8	3
T3/T4	78	50	28	0.576
N classification
N0/N1	39	26	13
N2/N3	50	32	18	0.794
Lymph node metastasis
Negative	23	10	13
Positive	66	48	18	0.012